First Time Loading...

CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 1.1 HKD 1.85% Market Closed
Updated: May 7, 2024

CStone Pharmaceuticals
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CStone Pharmaceuticals
Cash from Investing Activities Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
CStone Pharmaceuticals
HKEX:2616
Cash from Investing Activities
¥330.9m
CAGR 3-Years
-35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Investing Activities
¥2.4B
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Investing Activities
-¥1.1B
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Investing Activities
-¥2.1B
CAGR 3-Years
-91%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Investing Activities
-¥993.8m
CAGR 3-Years
-10%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Investing Activities
-¥943.7m
CAGR 3-Years
-233%
CAGR 5-Years
-143%
CAGR 10-Years
N/A

See Also

What is CStone Pharmaceuticals's Cash from Investing Activities?
Cash from Investing Activities
330.9m CNY

Based on the financial report for Dec 31, 2023, CStone Pharmaceuticals's Cash from Investing Activities amounts to 330.9m CNY.

What is CStone Pharmaceuticals's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-35%

Over the last year, the Cash from Investing Activities growth was -9%. The average annual Cash from Investing Activities growth rates for CStone Pharmaceuticals have been -35% over the past three years .